What is Scilligence?
Scilligence provides advanced informatics solutions tailored to optimize research and development workflows, thereby accelerating scientific discovery. Their comprehensive product suite encompasses an Electronic Lab Notebook (ELN), Registration and Assay Database (RegMol), Materials Inventory System, and Project Management Framework. These tools are crucial for clients operating in the biotech, pharmaceutical, chemical, and academic industries. A key differentiator for Scilligence is its integration of AI and machine learning capabilities, which enhance data capture and reporting efficiency. The company also prides itself on offering personalized support, delivered by scientists for scientists, aiming to align business objectives with cutting-edge technological advancements and facilitate the growth and integration of research teams.
How much funding has Scilligence raised?
Scilligence has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Scilligence?
With its recent major strategic investment and a history of substantial debt financing, Scilligence is well-positioned for its next phase of growth. The company's focus on AI-driven R&D optimization and its comprehensive informatics platform suggest a strategic direction towards deepening its market penetration and potentially expanding its service offerings. Future developments are likely to involve further integration of advanced analytics and machine learning to enhance scientific data management and accelerate drug discovery pipelines. This late-stage funding context implies a focus on scaling operations, expanding market reach, and potentially pursuing strategic partnerships or acquisitions to solidify its competitive advantage in the rapidly evolving scientific technology landscape.
See full Scilligence company page
